AroCell AB

AroCell AB AroCell develops and markets blood and urine sample tests to support the treatment of various cancers The corporation specializes in oncology and bacteriology.

AroCell AB is a Swedish IVD company that develops and markets blood and urine sample tests. The company has a broad product portfolio, used in healthcare, and established in various markets. In oncology, AroCell uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid

bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser.

Adress

Karlsbodavägen 39, Bromma
Stockholm
16867

Aviseringar

Var den första att veta och låt oss skicka ett mail när AroCell AB postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Affären

Skicka ett meddelande till AroCell AB:

Dela